METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY

Chimeric polypeptides and methods of altering the membrane localization of the same

CHIMERIC RECEPTORS CONTAINING TRAF-INDUCING DOMAINS AND RELATED COMPOSITIONS AND METHODS

Expression in mammalian cells with Gaussia luciferase signal peptide

Immunotherapy

Protein inhibitors to complement and VEGF pathways and methods of use thereof

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Transforming growth factor-beta-responsive polypeptides and their methods for use

Oligomers for TNF superfamily inhibition, methods of making and using

Chimeric antigen receptors and methods of use

Recombinant Mycobacterium Encoding A Heparin-Binding Hemagglutinin (HBHA) Fusion Protein And Uses Thereof

Methods for non-covalent Fc-domain-containing protein display on the surface of cells and methods of screening thereof

Intracellular protein delivery

Methods and compositions for synthesizing improved silk fibers

Compositions and methods for immunomodulation in an organism

Treatment of cancer using chimeric antigen receptor and protein kinase a blocker

Aminopeptidases for protein hydrolyzates

CHIMERIC POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME

CHIMERIC ANTIGEN RECEPTOR, REGULATORY CELLS AND METHODS OF USE

Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy

Methods and compositions for cells expressing a chimeric intracellular signaling molecule

CAR-EXPRESSING NK-92 CELLS AS CELL THERAPEUTIC AGENTS

Methods to protect transplanted tissue from rejection

CD8a and t cell receptor variants and methods of using same in modulating immune cell responses

Claudin-18.2-specific immunoreceptors and T cell epitopes

Compositions and methods for producing high secreted yields of recombinant proteins

Compositions and methods for producing high secreted yields of recombinant proteins

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

Methods and compositions for synthesizing improved silk fibers

Immune cell compositions and methods of use

Modified interleukin-7 protein

ERG targeted therapy

Chimeric inhibitor molecules of complement activation

Human cytomegalovirus RNA vaccines

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

ANTI-CD19 scFv (FMC63) POLYPEPTIDE AND USES THEREOF

Method of redirecting T cells to treat HIV infection

Method for producing fibroin-like protein

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

Endoglin polypeptides and uses thereof

De-Immunized, Shiga Toxin A Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same

Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereof

Biomarkers predictive of cytokine release syndrome

Methods of making serine proteases

Mesothelin-targeted chimeric antigen receptors and methods of making them

Prevention of N-terminal truncation in IgG light chains

Compositions and methods for TCR reprogramming using fusion proteins

Long-acting polypeptides and methods of producing and administering same

Single-chain light receptor agonist proteins

AAV-EPO for treating companion animals

Method of using mouse having a humanized cluster of differentiation 47 gene

Signal peptide, L-glutamic acid synthesized using konjac flour and methods of using same

Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Compositions and methods for TCR reprogramming using fusion proteins

Methods and compositions for cells expressing a chimeric intracellular signaling molecule

Compositions and methods for enhancing virus replication

Anti-alpha-synuclein antibodies and methods of use

Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, DNA, and vector

Compositions and methods for TCR reprogramming using fusion proteins

Antibodies to MUC16 and methods of use thereof

Anti-glypican-1-immunizing antigen receptor

Chimeric antigen receptors based on single domain antibodies and methods of use thereof

VEGFR-2 car immune cells to treat cancers

Antigen-binding proteins targeting CD56 and uses thereof

PROTOZOAN VARIANT-SPECIFIC SURFACE PROTEINS (VSP) AS CARRIERS FOR ORAL DRUG DELIVERY

Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infections

Fusion proteins and combination vaccines comprising haemophilus influenzae Protein E and Pilin A

PHI-4 polypeptides and methods for their use

REVERSAL AGENTS FOR FXIa INHIBITORS

CRYPTIC POLYPEPTIDES AND USES THEREOF

Adeno-associated viruses engineered for selectable tropism

Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteins

Anti-CD70 chimeric antigen receptors

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10

Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal

NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE

PROTEIN-PROTEIN INTERACTION DETECTION SYSTEMS AND METHODS OF USE THEREOF

GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereof

Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy

Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases

Cells producing glycoproteins having altered N- and O-glycosylation patterns and methods and use thereof

Chimeric antigen receptors (CARs), compositions and methods of use thereof

Chimeric receptors and methods of use thereof

Nucleic acids encoding artificial signal peptides and methods of production thereof

CHIMERIC RECEPTORS AND METHODS OF USE THEREOF

Methods and compositions for increasing red blood cells

Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies

Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

Recombinant vaccines and use thereof

RSV F protein mutants

Fusion constructs as protein over-expression vectors

Cryptic polypeptides and uses thereof

CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF

Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

Recombinant elastase proteins and methods of manufacturing and use thereof

Proteases with modified propeptide regions

Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor

Methods for preparing modified von Willebrand factor

Masking chimeric antigen receptor T cells for tumor-specific activation

Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies

Cadherin 26 (CDH26)-Fc fusion proteins and methods of use thereof to treat inflammatory conditions

Surface anchored light chain bait antibody display system

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

Antibacterial polypeptide libraries and methods for screening the same

Recombinant probiotic bacteria

IL13Rα2 binding agents and use thereof in cancer treatment

Antibody agents specific for human CD19 and uses thereof

Compositions and Methods of Use for Treating Metabolic Disorders

A Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Glioblastoma

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY

Expression process

Modified gamma delta T cells and uses thereof

Chimeric Receptors with 4-1BB Stimulatory Signaling Domain

FLT3 directed car cells for immunotherapy

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor

Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer

Humanized anti-MUC1* antibodies

Car t-cell therapy directed to LHR for the treatment of solid tumors

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

Dual specific anti-CD22-anti-CD19 chimeric antigen receptors

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

Modified UBE3A gene for a gene therapy approach for angelman syndrome

CHIMERIC CD27 RECEPTORS FOR REDIRECTING T CELLS TO CD70-POSITIVE MALIGNANCIES

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

Targeting GIV-GEF-GI signaling for treating diverse diseases

OPTIMIZED CHIMERIC RECEPTOR T CELL SWITCHES AND USES THEREOF

USE OF CAR-MODIFIED HUMAN NATURAL KILLER CELLS TO TREAT CANCER

Nucleic acid construct

Chimeric antigen receptors

Compositions and methods for modulating an immune response

Universal immune cells for cancer immunotherapy

Modified glucoamylase enzymes and yeast strains having enhanced bioproduct production

Constructs targeting AFP peptide/MHC complexes and uses thereof

Hepatitis B therapeutic vaccines

METHODS AND COMPOSITIONS FOR TREATING CANCER

Epidermal growth factor receptor targeted/immunomodulatory fusion proteins and methods of use for them

Single-chain CD40-receptor agonist proteins

Muteins of a1m lipocalin and method of production therefor

Cyclic galanin-analogs and uses thereof

Targeted therapeutic proteins

Method for production of heparin and heparan sulfate

Car-expressing cells against multiple tumor antigens and uses thereof

Polymeric Fc proteins and methods of screening to alter their functional characteristics

ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

Method for secretory production of protein

Compositions and methods for expressing polypeptides on the surface of cells

Beta-hexosyl-transferases and uses thereof

Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

NOVEL BINDING PROTEINS COMPRISING A UBIQUITIN MUTEIN AND ANTIBODIES OR ANTIBODY FRAGMENTS

Minor histocompatibility antigens and uses thereof

Composition and method for affecting the binding of antigen-binding polypeptides to antigens

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) BINDING AGENTS AND USES THEREOF

Bi-specific chimeric antigen receptor and uses thereof

Engineered T cells and uses therefor

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

CEACAM6 CAR immune cells to treat cancers

Chimeric antigen receptor signalling system comprising heterodimerization domains

ANTI-TAU CONSTRUCTS

Methods and compositions for modulating toso activity

Method for preparing mogroside having no β-1,6-glucoside bond

Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy

Method and compositions for cellular immunotherapy

CHIMERIC ANTIGEN RECEPTOR TARGETING OF TUMOR ENDOTHELIUM

Chimeric antigen receptors, compositions, and methods

CD33 specific chimeric antigen receptors

ANTI-HSP70 SPECIFIC CHIMERIC ANTIGEN RECEPTORS (CARS) FOR CANCER IMMUNOTHERAPY

Expression and secretion system

USE OF BLOCKING-REAGENTS FOR REDUCING UNSPECIFIC T CELL-ACTIVATION

Antibodies and immunocytokines

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

METHOD FOR THE PRODUCTION OF RECOMBINANT VIRUS, DNA CONSTRUCTS, RECOMBINANT VIRUS AND VACCINE COMPOSITIONS

Compositions and methods for T cell delivery of therapeutic molecules

CS1 targeted chimeric antigen receptor-modified T cells

Methods and compositions for transducing lymphocytes and regulating the activity thereof

Compositions and methods for improved car-T cell therapies

T CELL-BASED IMMUNOTHERAPEUTICS

ANTI-CD19 scFv (FMC63) POLYPEPTIDE

Peptide-hinge-free flexible antibody-like molecule

Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains

Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

TETRAVALENT TLR9 BISPECIFIC ANTIBODY

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

Modified kappa light chain-binding polypeptides

Compositions and methods for inhibition of lineage specific antigens

CS1-specific chimeric antigen receptor engineered immune effector cells

Modified kappa light chain-binding polypeptides

Polypeptide having a polyester degrading activity and uses thereof

NOVEL CHIMERIC ANTIGEN RECEPTORS

Compositions and cell-based methods for monitoring the activity of a Dengue Virus protease

Methods of treating cervical cancer

Methods and compositions for transducing lymphocytes and regulated expansion thereof

Glypican-3 antibody and uses thereof

Activation of adaptive immune processes for the treatment of cancers and infectious diseases

COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS

Chimeric receptors and methods of use thereof

ROR1 (NTRKR1) specific chimeric antigen receptors for cancer immunotherapy

Chimeric antigen receptor specific for SSEA4 antigen

Anti-hepatitis C antibodies and antigen binding fragments thereof

Chimeric antigen and T cell receptors and methods of use

CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy

Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof

Plant lectins as carriers of associated drug substances into animal and human cells

Systems for Factor VIII Processing and Methods Thereof

Transgene genetic tags and methods of use

Chimeric antigen receptors to control HIV infection

DNA antibody constructs and method of using same

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

Compositions and methods of stimulating and expanding T cells

SIGNAL PEPTIDE FUSION PARTNERS FACILITATING LISTERIAL EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS OF PREPARATION AND USE THEREOF

Stage specific diagnostic antigens, assay and vaccine for lyme disease

Compositions and methods for boosting the efficacy of adoptive cellular immunotherapy

Human alpha-folate receptor chimeric antigen receptor

Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders

Modulators of gamma-C-cytokine activity

Targeted/TGF-ßRII fusion proteins and methods for making same

METHODS AND COMPOSITIONS USING KLOTHO-FGF FUSION POLYPEPTIDES

RTEF-1 VARIANTS AND USES THEREOF

BCMA CHIMERIC ANTIGEN RECEPTORS

Methods and compositions for treating cancer

Enhanced production of immunoglobulins

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES

HUMAN APPLICATION OF ENGINEERED CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone

Methods of making T cell compositions

Antibody gene expression-secretion system

Sortase synthesized chimeric antigen receptors

Peptides for the specific binding of RNA targets

Treatment and prevention of malaria

Engineered cells for adoptive cell therapy

Immunologic effector cell of targeted CLD18A2, and preparation method and use thereof

Polypeptides having xylanase activity and polynucleotides encoding same

BSL2v2c2-Ig polypeptides

RECOMBINANT PROTEINS HAVING FACTOR H ACTIVITY

Heterologous polypeptide expression cassette

BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy

Chimeric antigen receptors and methods of making

RSV F protein mutants

CD40 ligand fusion protein vaccine

Methods and compositions for suppressing virulence of methicillin resistant

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Targeted disruption of the MHC cell receptor

COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS

Macrophage CAR (MOTO-CAR) in immunotherapy

Compositions and methods for TCR reprogramming using fusion proteins

Chimeric inhibitor molecules of complement activation

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

Dual cistronic bacterial expression system

Modified interleukin-7 protein

BIOTINYLATED PROTEIN

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses Thereof

Drug regulated transgene expression

NPP1 FUSION PROTEINS

HBV polymerase mutants

Chimeric antigen receptor hCD87-CAR and applications thereof

Chimeric antigen receptor and its use

Independently inducible system of gene expression

Car based immunotherapy

Mps1 and KNL1 phosphorylation system

CAR-expressing NK-92 cells as cell therapeutic agents

Modified latency associated protein construct

Capsular gram-positive bacteria bioconjugate vaccines

TEM8 ANTIBODIES AND METHODS OF USE

Anti-alpha-synuclein antibodies and methods of use

Chimeric antigen receptors targeting CD-19

Hybrid proteins and uses thereof

Bispecific antibody fragments for neurological disease proteins and methods of use

Modulating gamma-C-cytokine activity

Reducing immune tolerance induced by PD-L1

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

Delivery of Nrf2 as therapy for protection against reactive oxygen species

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

Mesothelin-targeted chimeric antigen receptors and uses thereof

GITRL-collectin fusion proteins and encoding nucleic acids

RTEF-1 variants and the use thereof for inhibition of angiogenesis

Adenoviral vector vaccine

Method and use for surface display of proteins and peptide derivatives in a bacterial thermophile

Detecting a therapeutic cell

Tetrameric cytokines with improved biological activity

MND promoter chimeric antigen receptors

Chloroplast transit peptides

Polypeptides having amylolytic enhancing activity and polynucleotides encoding same

Compositions and methods of chimeric autoantibody receptor T cells

KAPPA/LAMBDA CHIMERIC ANTIGEN RECEPTORS

CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies

Biomolecule-releasing cell and selection thereof by means of a surface protein

Ligands modified by circular permutation as agonists and antagonists

Interleukin 15 as selectable marker for gene transfer in lymphocytes

Protein secretory factor with high secretory efficiency and an expression vector comprising the same

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

Methods and compositions for secretion of heterologous polypeptides

Fusion proteins and combination vaccines comprising protein E and pilin A

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses